Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y (2017) Epidemiology of stone disease across the world. World J Urol 35(9):1301–1320

Article  PubMed  Google Scholar 

Scales CD Jr., Smith AC, Hanley JM, Saigal CS (2012) Prevalence of kidney stones in the United States. Eur Urol 62(1):160–165

Article  PubMed  PubMed Central  Google Scholar 

Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, Penniston KL, Preminger GM, Turk TM et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324

Article  PubMed  Google Scholar 

Wang L, Yin S, Li K-p, Bao E-h, Wang J-h (2023) Zhu P-yJFiG: the causal association between smoking, alcohol consumption and risk of upper urinary calculi: insights from a mendelian randomization study 14:1268720

Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, Burgess S, Jiang T, Paige E, Surendran P et al (2018) Genomic atlas of the human plasma proteome. Nature 558(7708):73–79

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang W, Xiao J, Ji J, Chen L (2021) Association of lipid-lowering drugs with COVID-19 outcomes from a mendelian randomization study. eLife 10

Fauman EB, Hyde C (2022) An optimal variant to gene distance window derived from an empirical definition of cis and trans protein QTLs. BMC Bioinformatics 23(1):169

Article  CAS  PubMed  PubMed Central  Google Scholar 

Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, Galver L, Kelley R, Karlsson A, Santos R et al (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med 9(383)

Vezzoli G, Terranegra A, Rainone F, Arcidiacono T, Cozzolino M, Aloia A, Dogliotti E, Cusi D (2011) Soldati LJJotm: calcium-sensing receptor and calcium kidney stones 9:1–9

Zhang G, Eddy (2008) AAJFibaj, library v: urokinase and its receptors in chronic kidney disease 13:5462

Smith GD, Ebrahim S (2003) Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32(1):1–22

Article  PubMed  Google Scholar 

Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-H, Richardson TG, Surendran P, Mahajan A, Robins C, Vasquez-Grinnell SGJB (2022) Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants 2022.2006. 2017.496443

Schmidt AF, Finan C, Gordillo-Marañón M, Asselbergs FW, Freitag DF, Patel RS, Tyl B, Chopade S, Faraway R (2020) Zwierzyna MJNc: genetic drug target validation using mendelian randomisation 11(1):3255

Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MAJN (2023) FinnGen provides genetic insights from a well-phenotyped isolated population 613(7944):508–518

Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N et al (2021) Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA 326(16):1614–1621

Article  PubMed  Google Scholar 

Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526(7571):68–74

Article  PubMed  Google Scholar 

Burgess S, Smith GD, Davies NM, Dudbridge F, Gill D, Glymour MM, Hartwig FP, Kutalik Z, Holmes MV (2019) Minelli CJWor: Guidelines for performing Mendelian randomization investigations: update for summer 2023. 4

Wallace, CJPg (2021) A more accurate method for colocalisation analysis allowing for multiple causal variants 17(9):e1009440

Su W-M, Gu X-J, Dou M, Duan Q-Q, Jiang Z, Yin K-F, Cai W-C, Cao B, Wang Y, Chen Y-PJJN, Neurosurgery et al (2023) Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease 94(11):954–961

Julian TH, Girach Z, Sanderson E, Guo H, Yu J, Cooper-Knock J, Black GC, Sergouniotis PIJSR (2023) Causal factors in primary open angle glaucoma: a phenome-wide mendelian randomisation study 13(1):9984

Cai Y-X, Wu Y-Q, Liu J, Pan H, Deng W, Sun W, Xie C, Huang X-FJBc (2023) Proteome-wide analysis reveals potential therapeutic targets for colorectal cancer: a two-sample mendelian randomization study 23(1):1188

Khan SR (2014) Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis. Translational Androl Urol 3(3):256–276

Google Scholar 

Iida S, Peck AB, Byer KJ, Khan SR (1999) Expression of bikunin mRNA in renal epithelial cells after oxalate exposure. J Urol 162(4):1480–1486

Article  CAS  PubMed  Google Scholar 

Dawson CJ, Grover PK, Kanellos J, Pham H, Kupczyk G, Oates A, Ryall RL (1998) Inter-alpha-inhibitor in calcium stones. Clin Sci (London England: 1979) 95(2):187–193

Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ (2007) Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int 72(12):1503–1511

Article  CAS  PubMed  Google Scholar 

Zhuo L, Kimata KJC (2008) Structure and function of inter-α-trypsin inhibitor heavy chains 49(5):311–320

Gao X-S, Pan J, Pang R, Liu B, Song S-QJAPM (2021) Mechanism of Huayu Jianpi Fangshi decoction in urolithiasis prevention: a randomized trial 10(4):4320327–4324327

Stridh S, Palm F, Hansell PJAJP-R, Integrative, Physiology C (2012) Renal interstitial hyaluronan: functional aspects during normal and pathological conditions 302(11):R1235–R1249

Verkoelen CJG (2007) The role of hyaluronan in renal stone disease 11:A3

Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, Petersen G, Lou Z, Wang L (2009) FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16(3):259–266

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robson T, James IF (2012) The therapeutic and diagnostic potential of FKBPL; a novel anticancer protein. Drug Discovery Today 17(11–12):544–548

Article  CAS  PubMed  Google Scholar 

Januszewski AS, Watson CJ, O’Neill V, McDonald K, Ledwidge M, Robson T, Jenkins AJ, Keech AC, McClements LJSr (2020) FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease 10(1):21655

Lu Z, Wang F, Liang MJCS (2017) SerpinC1/Antithrombin III in kidney-related diseases 131(9):823–831

Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JRJC (2002) Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration 110(5):639–648

Topolska-Woś AM, Chazin WJ, Filipek AJBeBA-GS (2016) CacyBP/SIP—structure and variety of functions 1860(1):79–85

Fard D, Testa E, Panzeri V, Rizzolio S, Bianchetti G, Napolitano V, Masciarelli S, Fazi F, Maulucci G, Scicchitano BMJC et al (2023) SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growth 80(4):111